In last trading session, BioAge Labs Inc (NASDAQ:BIOA) saw 4.7 million shares changing hands with its beta currently measuring 0. Company’s recent per share price level of $4.30 trading at $0.2 or 4.88% at ring of the bell on the day assigns it a market valuation of $154.16M. That closing price of BIOA’s stock is at a discount of -519.07% from its 52-week high price of $26.62 and is indicating a premium of 10.47% from its 52-week low price of $3.85. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 1.9 million shares which gives us an average trading volume of 669.34K if we extend that period to 3-months.

BioAge Labs Inc (NASDAQ:BIOA) trade information

Upright in the green during last session for gaining 4.88%, in the last five days BIOA remained trading in the red while hitting it’s week-highest on Wednesday, 12/18/24 when the stock touched $4.30 price level, adding 16.02% to its value on the day. BioAge Labs Inc’s shares saw a change of -76.52% in year-to-date performance and have moved -10.42% in past 5-day. BioAge Labs Inc (NASDAQ:BIOA) showed a performance of -76.27% in past 30-days. Number of shares sold short was 2.37 million shares which calculate 11.43 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 40 to the stock, which implies a rise of 89.25% to its current value. Analysts have been projecting 7 as a low price target for the stock while placing it at a high target of 45. It follows that stock’s current price would drop -62.79% in reaching the projected high whereas dropping to the targeted low would mean a loss of -62.79% for stock’s current value.